Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

Columbia University Medical Center, New York

Wills Eye Hospital, Philadelphia

Retina Consultants of Carolina, PA, Greenville

Emory Eye Center, Atlanta

Retina Associates of Florida, Tampa

St. Thomas Health / Tennessee Retina, PC, Nashville

Midwest Eye Institute, Carmel

Associated Retinal Consultants, PC, Royal Oak

W. K. Kellogg Eye Center, University of Michigan, Ann Arbor

University of Iowa Department of Ophthalmology and Visual Sciences, Iowa City

University of Wisconsin Dept of Ophthalmology & Visual Sciences, Madison

Retina Center, Minneapolis

University of Illinois At Chicago Illinois Eye and Ear Infirmary, Chicago

Dean McGee Eye Institute, Oklahoma City

Texas Retina Associates, Dallas

Retina Consultants of Houston, Houston

UCHealth Eye Center, Aurora

Retina Associates SW, P.C., Tucson

UCLA Jules Stein Eye Institute, Los Angeles

Byers Eye Institute at Stanford University, Palo Alto

Oregon Health & Science University Casey Eye Institute, Portland

Massachusetts Eye and Ear Infirmary, Boston